Search hospitals > Texas > Tyler
Texas Oncology - Tyler
Claim this profileTyler, Texas 75702
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Tumors
Conducts research for Cancer
310 reported clinical trials
7 medical researchers
Summary
Texas Oncology - Tyler is a medical facility located in Tyler, Texas. This center is recognized for care of Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Tumors, Cancer and other specialties. Texas Oncology - Tyler is involved with conducting 310 clinical trials across 174 conditions. There are 7 research doctors associated with this hospital, such as Donald A. Richards, Habte A Yimer, Anna Priebe, MD, and Sasha Davis.Area of expertise
1Breast Cancer
Global LeaderHER2 negative
Stage IV
Stage III
2Lung Cancer
Global LeaderStage IV
Stage III
PD-L1 negative
Top PIs
Donald A. RichardsTexas Oncology - Tyler4 years of reported clinical research
Studies Breast Cancer
Studies Non-Small Cell Lung Cancer
41 reported clinical trials
69 drugs studied
Habte A YimerTexas Oncology - Tyler5 years of reported clinical research
Studies Lymphoma
Studies Multiple Myeloma
19 reported clinical trials
37 drugs studied
Anna Priebe, MDTexas Oncology1 year of reported clinical research
Studies Ovarian Cancer
Studies Ovarian Tumors
11 reported clinical trials
20 drugs studied
Sasha DavisTexas Oncology - Tyler2 years of reported clinical research
Studies Breast Cancer
Studies Tumors
3 reported clinical trials
5 drugs studied
Clinical Trials running at Texas Oncology - Tyler
Colorectal Cancer
Cancer
Tumors
Solid Tumors
Breast Cancer
Pancreatic Cancer
Non-Small Cell Lung Cancer
Endometrial Cancer
Multiple Myeloma
Myelodysplastic Syndrome
SHP2 Inhibitor
for Solid Cancers
A Phase 1 dose escalation study in patients with advanced solid tumors harboring KRAS or EGFR mutations to determine the maximum tolerated dose and recommended Phase II dose of HBI-2376 and characterize its pharmacokinetic profile.
Recruiting1 award Phase 17 criteria
Combo Therapy
for Colorectal Cancer
This is a Phase 1b/2 study to investigate the efficacy and safety of LBL-007 plus Tislelizumab when administered in combination with bevacizumab plus fluoropyrimidine to participants with colorectal cancer.
Recruiting1 award Phase 1 & 2
MCLA-158
for Solid Cancers
This is a Phase 1/2 open-label, multi-center, multi-national study with an initial dose escalation part to determine the RP2D of MCLA-158 single agent in patients with mCRC. The dose escalation part has been completed and the RP2D will be further evaluated in an expansion part of the study. Cohorts of selected solid tumor indications for which there is evidence of EGFR dependency and potential sensitivity to EGFR inhibition will be evaluated including head and neck cancer. The study will further assess the safety, tolerability, PK, PD, immunogenicity, and anti-tumor activity of MCLA-158.
Recruiting1 award Phase 1 & 2
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Texas Oncology - Tyler?
Texas Oncology - Tyler is a medical facility located in Tyler, Texas. This center is recognized for care of Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Tumors, Cancer and other specialties. Texas Oncology - Tyler is involved with conducting 310 clinical trials across 174 conditions. There are 7 research doctors associated with this hospital, such as Donald A. Richards, Habte A Yimer, Anna Priebe, MD, and Sasha Davis.